{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T20:53:58Z","timestamp":1697403238574},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.det.2011.06.011","type":"journal-article","created":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T04:28:03Z","timestamp":1316233683000},"page":"681-683","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence and Treatment of Pemphigus in Iran"],"prefix":"10.1016","volume":"29","author":[{"given":"Cheyda","family":"Chams-Davatchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2011.06.011_bib1","unstructured":"Daneshpazhooh M, Chams-Davatchi C, Payandemehr P. Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Presented at 18th EADV Congress, October 7\u201310, 2009, Berlin\/Germany. p. 152."},{"key":"10.1016\/j.det.2011.06.011_bib2","unstructured":"Chams-Davatchi C, Daneshpazhooh M, Esmaili N. Analysis of 1782 pemphigus. Presented at 21st World Congress of Dematology, October 1\u20135, 2007, Buenos Aires (Argentina);75:1190."},{"key":"10.1016\/j.det.2011.06.011_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10875-008-9244-x","article-title":"HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris","volume":"29","author":"Shams","year":"2009","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.det.2011.06.011_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0198-8859(97)00182-1","article-title":"Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris; possible common central Asian ancestral origin","volume":"57","author":"Mobini","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.det.2011.06.011_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209 cases","volume":"44","author":"Chams- Davatchi","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-4632.2006.02916.x","article-title":"Value of direct immunofluorescence in predicting remission in pemphigus vulgaris","volume":"45","author":"Balighi","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of 4 treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2011.06.011_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archderm.144.9.1143","article-title":"Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris","volume":"144","author":"Firooz","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib11","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib12","first-page":"23","article-title":"Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris","volume":"129","author":"Chams-Davatchi","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2011.06.011_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A\u00a0single cycle for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2011.06.011_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.det.2011.06.011_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.det.2011.06.011_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2010.04.001","article-title":"Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies","volume":"64","author":"Lolis","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib17","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archdermatol.2008.503","article-title":"Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris","volume":"144","author":"Green","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.011_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A\u00a0randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863511001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863511001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:20:17Z","timestamp":1543544417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863511001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0733863511001197"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2011.06.011","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}